Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Robim M. Rodrigues"'
Autor:
Karolien Buyl, Makram Merimi, Robim M. Rodrigues, Saida Rahmani, Mohammad Fayyad-Kazan, Fatima Bouhtit, Noureddine Boukhatem, Tamara Vanhaecke, Hassan Fahmi, Joery De Kock, Mehdi Najar
Publikováno v:
Biomolecules, Vol 14, Iss 7, p 852 (2024)
Background: AT-MSCs display great immunoregulatory features, making them potential candidates for cell-based therapy. This study aimed to evaluate the “RBC lysis buffer” isolation protocol and immunological profiling of the so-obtained AT-MSCs. M
Externí odkaz:
https://doaj.org/article/ef1210ad818c4be8bbd3a1ff36e37c92
Autor:
Edyta Wieczorek, Anna Wolniakowska, Joanna Roszak, Robim M. Rodrigues, Tamara Vanhaecke, Edyta Reszka
Publikováno v:
Medycyna Pracy, Vol 74, Iss 2, Pp 127-144 (2023)
Bladder cancer (BCa) and prostate cancer (PCa) are genitourinary cancers which constitute significant health problems in men and in which environmental factors play an important role. Understanding the genetic susceptibility to BCa or PCa and occupat
Externí odkaz:
https://doaj.org/article/81d913708b0c4d0f9bb573fab5ddfe9d
Publikováno v:
eGastroenterology, Vol 1, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/53ba6a92961d40b098fe4c38a51adfa7
Autor:
Xiaolin Wang, Seung‐Jin Kim, Yukun Guan, Richard Parker, Robim M. Rodrigues, Dechun Feng, Shelly C. Lu, Bin Gao
Publikováno v:
Hepatology Communications, Vol 6, Iss 12, Pp 3335-3348 (2022)
Abstract Adipose tissue dysfunction is closely associated with the development and progression of nonalcoholic fatty liver disease (NAFLD). Recent studies have implied an important role of prohibitin‐1 (PHB1) in adipose tissue function. In the curr
Externí odkaz:
https://doaj.org/article/bbd7c2b7acd3476babc50995e6b7c67d
Autor:
Longshan Ji, Qian Li, Yong He, Xin Zhang, Zhenhua Zhou, Yating Gao, Miao Fang, Zhuo Yu, Robim M. Rodrigues, Yueqiu Gao, Man Li
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 9, Pp 3529-3547 (2022)
Nonalcoholic fatty liver disease (NAFLD) is characterized by excessive accumulation of hepatic lipids and metabolic stress-induced liver injury. There are currently no approved effective pharmacological treatments for NAFLD. Traditional Chinese medic
Externí odkaz:
https://doaj.org/article/f3a8f97e24d3457a9630c91a52684157
Autor:
Robim M. Rodrigues, Yong He, Seonghwan Hwang, Adeline Bertola, Bryan Mackowiak, Yeni Ait Ahmed, Wonhyo Seo, Jing Ma, Xiaolin Wang, Seol Hee Park, Yukun Guan, Yaojie Fu, Tamara Vanhaecke, Dechun Feng, Bin Gao
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 1, Pp 151-171 (2022)
Background & Aims: Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease, characterized by steatosis and hallmark liver neutrophil infiltration. NASH also is associated with adipose tissue inflammation, but the role of adipo
Externí odkaz:
https://doaj.org/article/9bc1e20fa00e4a4fafdb662818770db4
Autor:
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, Ger H. Koek, Robim M. Rodrigues, Tamara Vanhaecke
Publikováno v:
Liver International. 43:975-988
BACKGROUND: It is unclear whether the patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 C-to-G single nucleotide polymorphism, resulting in the substitution of isoleucine to methionine at position 148 (I148M), impedes regressio
Autor:
Joost Boeckmans, Alessandra Natale, Matthias Rombaut, Karolien Buyl, Tamara Vanhaecke, Vera Rogiers, Robim M Rodrigues, Joery De Kock
Publikováno v:
MethodsX, Vol 7, Iss , Pp 101068- (2020)
Non-alcoholic steatohepatitis (NASH) is a severe chronic liver disease that affects 3 to 5 percent of the world population. It is characterized by hepatic lipid accumulation and inflammation and can progress towards fibrosis, cirrhosis and hepatocell
Externí odkaz:
https://doaj.org/article/a3aff3daa9b64c03bede64425e26eb5e
Autor:
Joost Boeckmans, Alexandra Gatzios, Anja Heymans, Matthias Rombaut, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim M. Rodrigues
Publikováno v:
Cells, Vol 11, Iss 5, p 893 (2022)
Background and aims: Non-alcoholic steatohepatitis (NASH) is a life-threatening stage of non-alcoholic fatty liver disease (NAFLD) for which no drugs have been approved. We have previously shown that human-derived hepatic in vitro models can be used
Externí odkaz:
https://doaj.org/article/92afa28c530f405bbeeadc4e6899147e
Autor:
Alexandra Gatzios, Matthias Rombaut, Karolien Buyl, Joery De Kock, Robim M. Rodrigues, Vera Rogiers, Tamara Vanhaecke, Joost Boeckmans
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 161 (2022)
Although most same-stage non-alcoholic fatty liver disease (NAFLD) patients exhibit similar histologic sequelae, the underlying mechanisms appear to be highly heterogeneous. Therefore, it was recently proposed to redefine NAFLD to metabolic dysfuncti
Externí odkaz:
https://doaj.org/article/8a638736073742fd8a15086fda9c252f